Acknowledging trends is a key part of our daily news reportingroutine. For quite a while, BioWorld has taken note of the fact thatthere is an ever-expanding gray area between biotech therapeuticsand diagnostics.

Numerous fledgling and established biotechnology andpharmaceutical companies have realized that diagnostics are crucialto develop therapeutic strategies. As well, many companies haveproven that the launch of diagnostics can either lead to or fund drugdiscovery programs.

These are a few of the reasons why we are introducing, in today'sissue, Biotech Diagnostics, a separate page dedicated to diagnosticindustry news that will appear every other Wednesday. Overallcontent of the newsletter will not change; BioWorld Today willcontinue to provide the same news coverage of the industry asalways.

If you have any comments or questions, please feel free to call me at(404) 262-7759, extension 180. - Lynn Yoffee, managing editor

(c) 1997 American Health Consultants. All rights reserved.